EDSP Public Discussion

There will be a 4-day meeting of the Federal Insecticide, Fungicide, and Rodenticide Act Scientific Advisory Panel to consider and review the Endocrine Disruptor Screening Program Tier 1 Screening Assays and Battery Performance. The meeting will be held on May 21 – 24, 2013, from approximately 9 a.m. to 5 p.m., at the Environmental Protection Agency,
Conference Center, Lobby Level, One Potomac Yard (South Bldg.), 2777 S. Crystal Dr.,
Arlington, VA 22202. EPA encourages that written comments be submitted by May
7, 2013, and requests for oral comments be submitted by May 14, 2013. However,
written comments and requests to make oral comments may be submitted until the date of
the meeting. Anyone submitting written comments after May 7, 2013 should contact
Fred Jenkins Jr., DFO, Office of Science Coordination and Policy (7201M), Environmental Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460-0001; telephone number: (202) 564-3327; fax number: (202) 564-8382; email address: jenkins.fred@epa.gov

On March 7, 2013, at 1:15 p.m., EPA’s Science Advisory Board will review the draft SAB Report “SAB Advice (1/29/13 Draft) on Advancing the Application of CompTox Research for Human Health Risk Assessment.” A copy of this draft report is available here.

This draft report includes several recommendations, one of which is that “EPA should develop data use guidelines for information generated by CompTox, including ExpoCast, for the various purposes to which it is intended.”

The Environmental Protection Agency’s Science Advisory Board will meet publicly on March 7, 2013, from 10:30 a.m. to 6:00 p.m. and Friday, March 8, 2013, from 8:00 a.m. to 1:00 p.m. The SAB will perform a number of reviews at this meeting. One of them is a quality review of three draft SAB reports on the use of computational toxicology to advance risk Assessment. The SAB meeting will be held at the Washington Marriott, 1221 22nd Street NW, Washington, DC, 20037.

On January 29-31, the FIFRA Science Advisory Panel reviewed EPA’s current efforts to prioritize the universe of Endocrine Disruptor Screening Program chemicals using computational toxicology tools.  At this SAP meeting, EPA representatives stated that the Agency intends to convene three more SAPs in 2013 to review EDSP issues.  According to EPA:

● the first additional SAP will review some “operational aspects” of the current EDSP tier 1 tests;

● the second additional SAP will review the validation status of the EDSP Tier 2 tests that EPA is developing; and

● the third additional SAP will review EPA’s Weight of Evidence analysis of the EDSP Tier 1 test results.

EPA did not provide the dates for these additional SAPs.